US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

105.61

-0.2300-0.22%

Post-market: 105.630.0159+0.02%16:20 EDT

Volume:459.38K

Turnover:48.18M

Market Cap:5.91B

PE:-25.68

High:107.20

Open:105.33

Low:102.38

Close:105.84

52wk High:117.88

52wk Low:23.39

Shares:55.93M

Float Shares:55.85M

Volume Ratio:0.96

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.1130

EPS(LYR):-4.2037

ROE:-26.07%

ROA:-17.69%

PB:5.04

PE(LYR):-25.12

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Tenax Therapeutics (TENX) and Compass Therapeutics (CMPX)

Dianthus Therapeutics (DNTH) Receives a Buy from Guggenheim

Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (JAZZ), Dianthus Therapeutics (DNTH) and Waters (WAT)

Analysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Dianthus Therapeutics (DNTH)

LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis

Nanjing Leads Biolabs says LBL-047 Phase I trial starts in China for lupus

Dianthus reports Q1 EPS (85c), consensus ($1.10)

Dianthus Q1 FY26 net loss widens 38.37% to $40.8 million

Dianthus Therapeutics Inc Q1 Income From Operations USD -46.533 Million

THOMSON REUTERS

Press Release: Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results

Dianthus Therapeutics grants inducement stock options for 135,000 shares at $87.42

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Dianthus treatment of myasthenia gravis gets orphan status

Dianthus Therapeutics (DNTH) Is Up 10.1% After $719M Raise And Insider Sale Has The Bull Case Changed?

Simply Wall St.

Dianthus CFO Ryan Savitz disposes 8,224 shares for $738,460

Dianthus Therapeutics announces annual shareholder meeting notice

Dianthus Therapeutics grants 135,000 inducement stock options to eight new hires

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Dianthus CFO Ryan Savitz disposes of DNTH common shares worth $9.1 million

Dianthus Therapeutics director Paula Soteropoulos disposes of shares worth $0 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/DNTH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DNTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","market":"US","secType":"STK","nameCN":"Dianthus Therapeutics Inc.","latestPrice":105.61,"timestamp":1788206400000,"preClose":105.84,"halted":0,"volume":459375,"hourTrading":{"tag":"盘后","latestPrice":105.6259,"preClose":105.61,"latestTime":"16:20 EDT","volume":19557,"amount":2065446.2567699999,"timestamp":1788207638759,"change":0.0159,"changeRate":0.000151,"amplitude":0.011542},"delay":0,"changeRate":-0.0021730914588057823,"floatShares":55850100,"shares":55934399,"eps":-4.113023,"marketStatus":"Post-Mkt","change":-0.23,"latestTime":"08-31 18:38:14 EDT","open":105.33,"high":107.195,"low":102.38,"amount":48175252,"amplitude":0.045493,"askPrice":107.7,"askSize":18,"bidPrice":105.62,"bidSize":9,"shortable":3,"etf":0,"ttmEps":-4.113023,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":105.84,"preHourTrading":{"tag":"盘前","latestPrice":108.2848,"preClose":105.84,"latestTime":"08:44 EDT","volume":5,"amount":532.2848,"timestamp":1788180251696,"change":2.4448,"changeRate":0.023099,"amplitude":0.021587},"postHourTrading":{"tag":"盘后","latestPrice":105.6259,"preClose":105.61,"latestTime":"16:20 EDT","volume":19557,"amount":2065446.2567699999,"timestamp":1788207638759,"change":0.0159,"changeRate":0.000151,"amplitude":0.011542},"volumeRatio":0.95831,"impliedVol":0.5855,"impliedVolPercentile":0.3426},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","floatShares":55850100,"roa":"-17.69%","roe":"-26.07%","lyrEps":-4.203707,"volumeRatio":0.95831,"shares":55934399,"dividePrice":0,"high":107.195,"amplitude":0.045493,"preClose":105.84,"low":102.38,"week52Low":23.39,"pbRate":"5.04","psRate":"3102.54","week52High":117.875,"institutionHeld":0,"latestPrice":105.61,"committee":-0.333333,"eps":-4.113023,"divideRate":0,"volume":459375,"delay":0,"ttmEps":-4.113023,"open":105.33,"prevYearClose":41.21,"prevWeekClose":105.84,"prevMonthClose":106.92,"prevQuarterClose":97.48,"fiveDayClose":110.07,"twentyDayClose":106.02,"sixtyDayClose":84.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DNTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"DNTH","fiscalQuarterEnding":"2026/06","expectedEps":-0.93,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":-0.9},{"market":"US","date":"2026-05-05","symbol":"DNTH","fiscalQuarterEnding":"2026/03","expectedEps":-1.17,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2026-03-09","symbol":"DNTH","fiscalQuarterEnding":"2025/12","expectedEps":-0.98,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2025-11-05","symbol":"DNTH","fiscalQuarterEnding":"2025/09","expectedEps":-0.86,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":-0.97},{"market":"US","date":"2025-08-07","symbol":"DNTH","fiscalQuarterEnding":"2025/06","expectedEps":-0.86,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.88}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DNTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DNTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":16,"updateTime":1775880000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DNTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DNTH","date":"2026-08-28","current":-25.676978,"percent":0.023876,"low":-35.457817,"twenty":-18.006555,"median":-13.180199,"eighty":-6.54516,"high":-2.378652,"avg":-14.063026,"sd":8.001377,"marketCap":6238920522},"quantilePoints":[{"date":"2023-09-22","current":-6.821887,"twenty":-6.869759,"median":-6.842701,"eighty":-6.807317,"marketCap":194260047},{"date":"2023-09-29","current":-5.576152,"twenty":-6.838538,"median":-5.576152,"eighty":-5.435929,"marketCap":201460812},{"date":"2023-10-06","current":-4.920135,"twenty":-6.800032,"median":-5.4757,"eighty":-5.354747,"marketCap":177759540},{"date":"2023-10-13","current":-4.916034,"twenty":-6.077097,"median":-5.403948,"eighty":-4.942276,"marketCap":177611407},{"date":"2023-10-20","current":-5.11694,"twenty":-5.587632,"median":-5.309646,"eighty":-5.016077,"marketCap":184869921},{"date":"2023-10-27","current":-4.75613,"twenty":-5.576152,"median":-5.262494,"eighty":-4.957036,"marketCap":171834222},{"date":"2023-11-03","current":-4.920135,"twenty":-5.49415,"median":-5.12514,"eighty":-4.920135,"marketCap":177759540},{"date":"2023-11-10","current":-4.678228,"twenty":-5.457249,"median":-5.084139,"eighty":-4.879133,"marketCap":169019695},{"date":"2023-11-17","current":-3.935775,"twenty":-5.444949,"median":-4.957036,"eighty":-4.76023,"marketCap":169663374},{"date":"2023-11-24","current":-4.021709,"twenty":-5.412148,"median":-4.920135,"eighty":-4.674948,"marketCap":173367815},{"date":"2023-12-01","current":-3.842966,"twenty":-5.377707,"median":-4.920135,"eighty":-3.993522,"marketCap":165662579},{"date":"2023-12-08","current":-3.640162,"twenty":-5.338346,"median":-4.907834,"eighty":-3.949524,"marketCap":156920099},{"date":"2023-12-15","current":-2.684576,"twenty":-5.297345,"median":-4.846332,"eighty":-3.884902,"marketCap":115726721},{"date":"2023-12-22","current":-3.007688,"twenty":-5.267824,"median":-4.788931,"eighty":-3.85534,"marketCap":129655417},{"date":"2023-12-29","current":-3.482043,"twenty":-5.235843,"median":-4.75818,"eighty":-3.842966,"marketCap":150103929},{"date":"2024-01-05","current":-4.482315,"twenty":-5.235843,"median":-4.715129,"eighty":-3.861528,"marketCap":193223616},{"date":"2024-01-12","current":-4.05952,"twenty":-5.169421,"median":-4.670027,"eighty":-3.873902,"marketCap":174997769},{"date":"2024-01-19","current":-3.952961,"twenty":-5.12186,"median":-4.521845,"eighty":-3.879402,"marketCap":170404263},{"date":"2024-01-26","current":-6.135656,"twenty":-5.267824,"median":-4.661827,"eighty":-3.893152,"marketCap":264495873},{"date":"2024-02-02","current":-14.091886,"twenty":-5.428549,"median":-4.735629,"eighty":-3.901401,"marketCap":607473021},{"date":"2024-02-09","current":-15.77856,"twenty":-5.593373,"median":-4.788931,"eighty":-3.913775,"marketCap":680182147},{"date":"2024-02-16","current":-16.247836,"twenty":-6.141843,"median":-4.875033,"eighty":-3.933712,"marketCap":700411702},{"date":"2024-02-23","current":-16.322648,"twenty":-6.585949,"median":-4.911934,"eighty":-3.935775,"marketCap":703636704},{"date":"2024-03-01","current":-16.832731,"twenty":-6.855189,"median":-4.920135,"eighty":-3.939212,"marketCap":725625351},{"date":"2024-03-08","current":-17.220393,"twenty":-14.108208,"median":-4.920135,"eighty":-3.952961,"marketCap":742336722},{"date":"2024-03-15","current":-18.274564,"twenty":-15.869694,"median":-5.055438,"eighty":-3.952961,"marketCap":787779926},{"date":"2024-03-22","current":-19.002283,"twenty":-16.27504,"median":-5.103895,"eighty":-3.958461,"marketCap":819150396},{"date":"2024-03-28","current":-20.617859,"twenty":-16.390659,"median":-5.12104,"eighty":-3.98046,"marketCap":898010856},{"date":"2024-04-05","current":-16.662734,"twenty":-16.662734,"median":-5.235843,"eighty":-3.987335,"marketCap":725745374},{"date":"2024-04-12","current":-16.777278,"twenty":-16.777278,"median":-5.350646,"eighty":-3.990772,"marketCap":730734324},{"date":"2024-04-19","current":-15.922581,"twenty":-16.832731,"median":-5.444949,"eighty":-3.99421,"marketCap":693508032},{"date":"2024-04-26","current":-14.143673,"twenty":-16.777278,"median":-5.535151,"eighty":-4.021709,"marketCap":616027659},{"date":"2024-05-03","current":-16.178636,"twenty":-16.662734,"median":-5.637242,"eighty":-4.021709,"marketCap":704660510},{"date":"2024-05-10","current":-14.570862,"twenty":-16.662734,"median":-6.140812,"eighty":-4.049207,"marketCap":731661246},{"date":"2024-05-17","current":-15.342363,"twenty":-16.621896,"median":-6.530951,"eighty":-4.05952,"marketCap":770401432},{"date":"2024-05-24","current":-12.724299,"twenty":-16.45867,"median":-6.737265,"eighty":-4.100768,"marketCap":638937940},{"date":"2024-05-31","current":-12.098897,"twenty":-16.404261,"median":-6.842701,"eighty":-4.106268,"marketCap":607534008},{"date":"2024-06-07","current":-12.233329,"twenty":-16.390659,"median":-12.098897,"eighty":-4.121392,"marketCap":614284386},{"date":"2024-06-14","current":-15.75779,"twenty":-16.354335,"median":-12.233329,"eighty":-4.176389,"marketCap":791261684},{"date":"2024-06-21","current":-15.114854,"twenty":-16.327131,"median":-12.630781,"eighty":-4.296009,"marketCap":758977268},{"date":"2024-06-28","current":-14.565435,"twenty":-16.324142,"median":-12.706764,"eighty":-4.381256,"marketCap":731388767},{"date":"2024-07-05","current":-15.459702,"twenty":-16.325636,"median":-12.794437,"eighty":-4.452753,"marketCap":776293455},{"date":"2024-07-12","current":-16.932611,"twenty":-16.417863,"median":-13.066224,"eighty":-4.47819,"marketCap":850254116},{"date":"2024-07-15","current":-16.920921,"twenty":-16.466954,"median":-13.180199,"eighty":-4.480252,"marketCap":849667127},{"date":"2024-08-02","current":-16.371502,"twenty":-16.45867,"median":-13.180199,"eighty":-4.482315,"marketCap":822078626},{"date":"2024-08-09","current":-13.845994,"twenty":-16.50009,"median":-13.738229,"eighty":-4.561374,"marketCap":784804801},{"date":"2024-08-16","current":-15.438194,"twenty":-16.45867,"median":-13.792112,"eighty":-4.661827,"marketCap":875052279},{"date":"2024-08-23","current":-14.304023,"twenty":-16.390659,"median":-14.112289,"eighty":-4.678228,"marketCap":810766318},{"date":"2024-08-30","current":-14.899592,"twenty":-16.390659,"median":-14.219338,"eighty":-4.715129,"marketCap":844523786},{"date":"2024-09-06","current":-14.490462,"twenty":-16.375333,"median":-14.311791,"eighty":-4.74793,"marketCap":821333873},{"date":"2024-09-13","current":-14.402421,"twenty":-16.338396,"median":-14.319559,"eighty":-4.75941,"marketCap":816343639},{"date":"2024-09-20","current":-14.552608,"twenty":-16.324142,"median":-14.311791,"eighty":-4.783191,"marketCap":824856392},{"date":"2024-09-27","current":-13.993291,"twenty":-16.306326,"median":-14.304023,"eighty":-4.815172,"marketCap":793153726},{"date":"2024-10-04","current":-14.221161,"twenty":-16.285922,"median":-14.291076,"eighty":-4.861093,"marketCap":806069627},{"date":"2024-10-11","current":-14.672555,"twenty":-16.269355,"median":-14.319559,"eighty":-4.877493,"marketCap":831655088},{"date":"2024-10-18","current":-14.522306,"twenty":-16.254626,"median":-14.311791,"eighty":-4.902094,"marketCap":823138846},{"date":"2024-10-25","current":-14.475677,"twenty":-16.248614,"median":-14.360865,"eighty":-4.914394,"marketCap":820495874},{"date":"2024-10-31","current":-14.486039,"twenty":-16.239675,"median":-14.366036,"eighty":-4.918495,"marketCap":821083201},{"date":"2024-11-08","current":-13.087312,"twenty":-16.213004,"median":-14.381745,"eighty":-4.920135,"marketCap":878053924},{"date":"2024-11-15","current":-11.244659,"twenty":-16.189942,"median":-14.360865,"eighty":-4.920135,"marketCap":754426637},{"date":"2024-11-22","current":-8.941908,"twenty":-16.180782,"median":-14.311791,"eighty":-4.920135,"marketCap":599930480},{"date":"2024-11-29","current":-10.582949,"twenty":-16.17095,"median":-14.273283,"eighty":-4.920135,"marketCap":710031190},{"date":"2024-12-06","current":-10.437372,"twenty":-16.142849,"median":-14.241876,"eighty":-4.934895,"marketCap":700264191},{"date":"2024-12-13","current":-10.36679,"twenty":-16.097823,"median":-14.188265,"eighty":-4.996397,"marketCap":695528677},{"date":"2024-12-20","current":-10.163866,"twenty":-16.05809,"median":-14.112289,"eighty":-5.061998,"marketCap":681914073},{"date":"2024-12-27","current":-10.14622,"twenty":-16.019613,"median":-14.091886,"eighty":-5.076759,"marketCap":680730195},{"date":"2025-01-03","current":-10.234448,"twenty":-15.922581,"median":-13.957579,"eighty":-5.096439,"marketCap":686649588},{"date":"2025-01-10","current":-11.284361,"twenty":-15.89482,"median":-13.822388,"eighty":-5.108369,"marketCap":757090364},{"date":"2025-01-17","current":-8.474299,"twenty":-15.887478,"median":-13.728741,"eighty":-5.115822,"marketCap":568557697},{"date":"2025-01-24","current":-9.828599,"twenty":-15.834329,"median":-13.708453,"eighty":-5.12186,"marketCap":659420380},{"date":"2025-01-31","current":-9.603618,"twenty":-15.788231,"median":-13.553088,"eighty":-5.191562,"marketCap":644325928},{"date":"2025-02-07","current":-10.128574,"twenty":-15.779567,"median":-13.462457,"eighty":-5.235843,"marketCap":679546316},{"date":"2025-02-14","current":-10.644708,"twenty":-15.766098,"median":-13.180199,"eighty":-5.267824,"marketCap":714174765},{"date":"2025-02-21","current":-10.455018,"twenty":-15.745542,"median":-13.087312,"eighty":-5.305545,"marketCap":701448070},{"date":"2025-02-28","current":-9.285997,"twenty":-15.702913,"median":-12.81575,"eighty":-5.346546,"marketCap":623016113},{"date":"2025-03-07","current":-10.375613,"twenty":-15.663831,"median":-12.724299,"eighty":-5.384267,"marketCap":696120616},{"date":"2025-03-14","current":-8.045567,"twenty":-15.60664,"median":-12.588406,"eighty":-5.420348,"marketCap":683623809},{"date":"2025-03-21","current":-7.727979,"twenty":-15.500032,"median":-12.233329,"eighty":-5.449869,"marketCap":656638658},{"date":"2025-03-28","current":-7.512473,"twenty":-15.459702,"median":-12.013661,"eighty":-5.472009,"marketCap":638327306},{"date":"2025-04-04","current":-6.416037,"twenty":-15.451099,"median":-11.624039,"eighty":-5.526951,"marketCap":545164287},{"date":"2025-04-11","current":-5.898066,"twenty":-15.431979,"median":-11.290978,"eighty":-5.587632,"marketCap":501152792},{"date":"2025-04-17","current":-7.175981,"twenty":-15.413286,"median":-11.262304,"eighty":-5.60754,"marketCap":609735897},{"date":"2025-04-25","current":-8.026663,"twenty":-15.369114,"median":-11.0285,"eighty":-5.622077,"marketCap":682017550},{"date":"2025-05-02","current":-8.204554,"twenty":-15.321347,"median":-10.898364,"eighty":-5.689407,"marketCap":697132746},{"date":"2025-05-09","current":-7.796217,"twenty":-15.230244,"median":-10.759405,"eighty":-5.898822,"marketCap":662436738},{"date":"2025-05-16","current":-5.986178,"twenty":-15.201008,"median":-10.704262,"eighty":-5.916298,"marketCap":602999662},{"date":"2025-05-23","current":-5.861665,"twenty":-15.193619,"median":-10.675588,"eighty":-5.916298,"marketCap":590457269},{"date":"2025-05-30","current":-5.698841,"twenty":-15.181369,"median":-10.600594,"eighty":-5.861665,"marketCap":574055678},{"date":"2025-06-06","current":-5.92871,"twenty":-15.126544,"median":-10.582949,"eighty":-5.698841,"marketCap":597210865},{"date":"2025-06-13","current":-6.15858,"twenty":-15.114854,"median":-10.503543,"eighty":-5.724382,"marketCap":620366052},{"date":"2025-06-20","current":-5.567944,"twenty":-15.086799,"median":-10.455018,"eighty":-5.687986,"marketCap":560870086},{"date":"2025-06-27","current":-5.788235,"twenty":-15.056571,"median":-10.424138,"eighty":-5.643102,"marketCap":583060473},{"date":"2025-07-03","current":-6.018104,"twenty":-15.025316,"median":-10.371201,"eighty":-5.641637,"marketCap":606215660},{"date":"2025-07-11","current":-6.580007,"twenty":-15.002134,"median":-10.30503,"eighty":-5.677131,"marketCap":662817229},{"date":"2025-07-18","current":-6.496998,"twenty":-14.98745,"median":-10.28959,"eighty":-5.714166,"marketCap":654455633},{"date":"2025-07-25","current":-6.956737,"twenty":-14.950568,"median":-10.234448,"eighty":-5.730129,"marketCap":700766007},{"date":"2025-08-01","current":-6.599162,"twenty":-14.912021,"median":-10.163866,"eighty":-5.73396,"marketCap":664746827},{"date":"2025-08-08","current":-6.113883,"twenty":-14.897039,"median":-10.14622,"eighty":-5.764609,"marketCap":615863655},{"date":"2025-08-15","current":-5.680098,"twenty":-14.891675,"median":-10.102106,"eighty":-5.714166,"marketCap":651813986},{"date":"2025-08-22","current":-6.633794,"twenty":-14.884329,"median":-10.031524,"eighty":-5.730129,"marketCap":761254359},{"date":"2025-08-29","current":-6.959172,"twenty":-14.857999,"median":-9.84404,"eighty":-5.73396,"marketCap":798592839},{"date":"2025-09-05","current":-6.917097,"twenty":-14.83641,"median":-9.826394,"eighty":-5.754393,"marketCap":793764587},{"date":"2025-09-12","current":-10.61968,"twenty":-14.806372,"median":-9.828599,"eighty":-5.786319,"marketCap":1218650741},{"date":"2025-09-19","current":-13.100588,"twenty":-14.770844,"median":-9.916203,"eighty":-5.789512,"marketCap":1503344826},{"date":"2025-09-26","current":-12.079369,"twenty":-14.762402,"median":-10.031524,"eighty":-5.797813,"marketCap":1386155868},{"date":"2025-10-03","current":-12.446738,"twenty":-14.758601,"median":-10.102106,"eighty":-5.811222,"marketCap":1428312952},{"date":"2025-10-10","current":-11.711999,"twenty":-14.750427,"median":-10.14622,"eighty":-5.817199,"marketCap":1343998784},{"date":"2025-10-17","current":-12.133294,"twenty":-14.726754,"median":-10.163866,"eighty":-5.821144,"marketCap":1392344064},{"date":"2025-10-24","current":-11.213186,"twenty":-14.705712,"median":-10.234448,"eighty":-5.826546,"marketCap":1286757972},{"date":"2025-10-31","current":-11.371593,"twenty":-14.704884,"median":-10.28959,"eighty":-5.834208,"marketCap":1304935797},{"date":"2025-11-07","current":-11.48051,"twenty":-14.703303,"median":-10.30503,"eighty":-5.84678,"marketCap":1450505040},{"date":"2025-11-14","current":-12.047161,"twenty":-14.690699,"median":-10.355761,"eighty":-5.85115,"marketCap":1522098532},{"date":"2025-11-21","current":-13.706615,"twenty":-14.666007,"median":-10.410904,"eighty":-5.857834,"marketCap":1731762245},{"date":"2025-11-28","current":-14.924905,"twenty":-14.703472,"median":-10.441784,"eighty":-5.865182,"marketCap":1885687139},{"date":"2025-12-05","current":-15.172635,"twenty":-14.705712,"median":-10.501337,"eighty":-5.879885,"marketCap":1916986630},{"date":"2025-12-12","current":-14.127417,"twenty":-14.759182,"median":-10.582949,"eighty":-5.885547,"marketCap":1784928504},{"date":"2025-12-19","current":-14.16814,"twenty":-14.753642,"median":-10.600594,"eighty":-5.898822,"marketCap":1790073626},{"date":"2025-12-26","current":-14.643239,"twenty":-14.756857,"median":-10.62529,"eighty":-5.901847,"marketCap":1850100047},{"date":"2026-01-02","current":-13.984887,"twenty":-14.743997,"median":-10.660148,"eighty":-5.923337,"marketCap":1766920578},{"date":"2026-01-09","current":-12.936275,"twenty":-14.712726,"median":-10.702056,"eighty":-5.944035,"marketCap":1634433691},{"date":"2026-01-16","current":-14.931692,"twenty":-14.757438,"median":-10.748376,"eighty":-5.968854,"marketCap":1886544660},{"date":"2026-01-23","current":-17.904456,"twenty":-14.780844,"median":-10.845427,"eighty":-5.981347,"marketCap":2262138551},{"date":"2026-01-30","current":-18.10807,"twenty":-14.824694,"median":-10.944683,"eighty":-5.986178,"marketCap":2287864160},{"date":"2026-02-06","current":-15.93519,"twenty":-14.884329,"median":-11.08833,"eighty":-5.986178,"marketCap":2013331532},{"date":"2026-02-13","current":-16.243083,"twenty":-14.922869,"median":-11.213186,"eighty":-6.003418,"marketCap":2052232313},{"date":"2026-02-20","current":-17.009395,"twenty":-14.931281,"median":-11.273853,"eighty":-6.016188,"marketCap":2149052034},{"date":"2026-02-27","current":-18.169127,"twenty":-14.990963,"median":-11.290903,"eighty":-6.018104,"marketCap":2295578309},{"date":"2026-03-06","current":-21.015429,"twenty":-15.068178,"median":-11.337298,"eighty":-6.018104,"marketCap":2655194418},{"date":"2026-03-13","current":-25.621671,"twenty":-15.177875,"median":-11.385074,"eighty":-6.024489,"marketCap":4159345176},{"date":"2026-03-20","current":-26.089965,"twenty":-15.231785,"median":-11.48051,"eighty":-6.051946,"marketCap":4235366640},{"date":"2026-03-27","current":-26.88897,"twenty":-15.431979,"median":-11.614259,"eighty":-6.085126,"marketCap":4365074743},{"date":"2026-04-02","current":-27.577093,"twenty":-15.513476,"median":-11.659593,"eighty":-6.095957,"marketCap":4476782538},{"date":"2026-04-10","current":-29.892577,"twenty":-15.723501,"median":-11.711999,"eighty":-6.103666,"marketCap":4852671327},{"date":"2026-04-17","current":-31.159199,"twenty":-15.795386,"median":-11.782777,"eighty":-6.118238,"marketCap":5058290825},{"date":"2026-04-24","current":-30.126149,"twenty":-15.915641,"median":-11.928426,"eighty":-6.137718,"marketCap":4890588611},{"date":"2026-05-01","current":-29.448629,"twenty":-16.107907,"median":-12.031246,"eighty":-6.145968,"marketCap":4780602093},{"date":"2026-05-08","current":-26.905004,"twenty":-16.195881,"median":-12.098897,"eighty":-6.147213,"marketCap":4672322934},{"date":"2026-05-15","current":-26.864081,"twenty":-16.242399,"median":-12.166998,"eighty":-6.153471,"marketCap":4665216324},{"date":"2026-05-22","current":-28.214525,"twenty":-16.27872,"median":-12.233329,"eighty":-6.161677,"marketCap":4899734463},{"date":"2026-05-29","current":-28.601716,"twenty":-16.322648,"median":-12.250775,"eighty":-6.174066,"marketCap":4966973930},{"date":"2026-06-05","current":-26.483187,"twenty":-16.390659,"median":-12.342225,"eighty":-6.286285,"marketCap":4599070182},{"date":"2026-06-12","current":-24.065608,"twenty":-16.50009,"median":-12.423847,"eighty":-6.334174,"marketCap":4179233512},{"date":"2026-06-18","current":-25.77806,"twenty":-16.674626,"median":-12.483812,"eighty":-6.35732,"marketCap":4476617820},{"date":"2026-06-26","current":-28.825216,"twenty":-16.833169,"median":-12.529311,"eighty":-6.366477,"marketCap":5005786955},{"date":"2026-07-02","current":-28.397103,"twenty":-16.886616,"median":-12.587383,"eighty":-6.383828,"marketCap":4931440878},{"date":"2026-07-10","current":-31.488329,"twenty":-16.971178,"median":-12.706764,"eighty":-6.400581,"marketCap":5468263286},{"date":"2026-07-17","current":-30.015118,"twenty":-17.063513,"median":-12.745015,"eighty":-6.408243,"marketCap":5212425316},{"date":"2026-07-24","current":-32.986724,"twenty":-17.117869,"median":-12.811972,"eighty":-6.413941,"marketCap":5728474556},{"date":"2026-07-31","current":-35.457817,"twenty":-17.32377,"median":-12.926095,"eighty":-6.448421,"marketCap":6157604485},{"date":"2026-08-07","current":-31.981455,"twenty":-17.376826,"median":-12.956139,"eighty":-6.502106,"marketCap":6148306829},{"date":"2026-08-14","current":-31.88835,"twenty":-17.609184,"median":-13.100588,"eighty":-6.511046,"marketCap":6130407828},{"date":"2026-08-21","current":-31.862165,"twenty":-17.914327,"median":-13.13035,"eighty":-6.520157,"marketCap":6125373734},{"date":"2026-08-28","current":-32.452798,"twenty":-18.006555,"median":-13.180199,"eighty":-6.54516,"marketCap":6238920522}],"updateTime":1788215892031},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DNTH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634460443","title":"Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Tenax Therapeutics (TENX) and Compass Therapeutics (CMPX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634460443","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634460443?lang=en_us&edition=fundamental","pubTime":"2026-05-10 10:10","pubTimestamp":1778379005,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dianthus Therapeutics (DNTH), Tenax Therapeutics (TE...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dianthus-therapeutics-dnth-tenax-therapeutics-tenx-and-compass-therapeutics-cmpx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dianthus-therapeutics-dnth-tenax-therapeutics-tenx-and-compass-therapeutics-cmpx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","LU0128526141.USD","CMPX","LU0029874061.USD","BK4588","LABU","XLV","DNTH","HCSG","BK4581","XBI","TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187571","title":"Dianthus Therapeutics (DNTH) Receives a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187571?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:20","pubTimestamp":1778066449,"startTime":"0","endTime":"0","summary":"In a report released today, Yatin Suneja from Guggenheim reiterated a Buy rating on Dianthus Therapeutics, with a price target of $200.00. Suneja c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-receives-a-buy-from-guggenheim-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-receives-a-buy-from-guggenheim-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633092184","title":"Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (JAZZ), Dianthus Therapeutics (DNTH) and Waters (WAT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633092184","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633092184?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:40","pubTimestamp":1778064054,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Jazz Pharmaceuticals (JAZZ), Dianthus Therapeutics...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-jazz-pharmaceuticals-jazz-dianthus-therapeutics-dnth-and-waters-wat-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-jazz-pharmaceuticals-jazz-dianthus-therapeutics-dnth-and-waters-wat-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0823416689.USD","BK4532","BK4533","LU2404859667.USD","XBI","BK4581","BK4588","LU0690374615.EUR","LU0109394709.USD","IE00BN0W2T93.GBP","HCSG","LU2404859741.USD","WAT","GB00B4QBRK32.GBP","IE00BN0W2W23.USD","BK4585","JAZZ","IE00BN0W2V16.EUR","LU0690374961.EUR","LU0154245673.USD","LU2413666426.HKD","GB00B4LPDJ14.GBP","LU0128526141.USD","LU1721428933.USD","LU0029874061.USD","BK4139","DNTH","LU0889565916.HKD","LABU","LU2413666699.HKD","XLV","LU0347712357.USD","LU0154245756.USD","BK4121","BK4137","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633901053","title":"Analysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Dianthus Therapeutics (DNTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633901053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633901053?lang=en_us&edition=fundamental","pubTime":"2026-05-06 15:20","pubTimestamp":1778052008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Myriad Genetics (MYGN) and Dianthus Therapeutics (DN...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-myriad-genetics-mygn-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-myriad-genetics-mygn-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","DNTH","LU0128526141.USD","HCSG","BK4139","XBI","BK4581","BK4137","LABU","BK4588","MYGN","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633972146","title":"LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis","url":"https://stock-news.laohu8.com/highlight/detail?id=2633972146","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633972146?lang=en_us&edition=fundamental","pubTime":"2026-05-06 10:57","pubTimestamp":1778036220,"startTime":"0","endTime":"0","summary":"NANJING, China, May  05, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (\"Leads Biolabs\"; Stock Code: 9887.HK) today announced that its partner, Dianthus Therapeutics, Inc. (“Dianthus”; NASD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288455/0/en/LBL-047-Prioritized-for-Clinical-Development-in-Sj%C3%B6gren-s-Disease-Systemic-Lupus-Erythematosus-and-Dermatomyositis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DM","BK4139","SLE","BK4077","BK4546","DNTH","BK4161","TACI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633097661","title":"Nanjing Leads Biolabs says LBL-047 Phase I trial starts in China for lupus","url":"https://stock-news.laohu8.com/highlight/detail?id=2633097661","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633097661?lang=en_us&edition=fundamental","pubTime":"2026-05-06 08:30","pubTimestamp":1778027421,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs partner Dianthus Therapeutics prioritized LBL-047 for clinical development in Sjgren’s disease, systemic lupus erythematosus, and dermatomyositis, positioning the asset as a core program for multiple autoimmune indications.Phase I study started in China in December 2025, enrolling healthy volunteers and systemic lupus erythematosus patients, with results not yet presented.Top-line readout from healthy-volunteer cohort expected in 2H 2026, setting up decisions on next clinical steps across prioritized indications.Dianthus completed an upsized underwritten public offering in March 2026 that raised about USD 719 million, strengthening funding for global development.LBL-047 combines two mechanisms intended to reduce autoimmune activity, supporting a potential subcutaneous self-administration regimen with dosing every four weeks or less.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provid","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL2PMx5t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNTH","HK0000252152.HKD","HK0000500386.USD","09887","BK1161","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633992942","title":"Dianthus reports Q1 EPS (85c), consensus ($1.10)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633992942","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633992942?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:18","pubTimestamp":1778012318,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $463,000, consensus $358,690. “Q1 of this year was a pivotal period for Dianthus (DNTH) as we were able to make an early GO deci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-reports-q1-eps-85c-consensus-1-10-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-reports-q1-eps-85c-consensus-1-10-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633926830","title":"Dianthus Q1 FY26 net loss widens 38.37% to $40.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633926830","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633926830?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:05","pubTimestamp":1778011513,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics posted Q1 net loss of USD 40.8 million, widening from USD 29.5 million a year earlier; loss per share widened to USD 0.85 from USD 0.82.Revenue fell to USD 463,000 from USD 1.16 million; R&D expense climbed to USD 34.5 million from USD 27 million.G&A expense rose to USD 12.5 million from USD 7.3 million; cash, cash equivalents and investments totaled about USD 1.2 billion at March 31, 2026, with expected runway into 2030.CAPTIVATE CIDP study reached an early GO decision in March 2026 after 20 confirmed responders with fewer than 40 planned participants completing open-label Part A; CAPTIVATE Part B top-line guidance expected by year-end 2026.Phase 3 EMERGE trial in generalized myasthenia gravis on track to start mid-2026 with top-line results anticipated in 2H’28; Phase 2 MoMeNtum trial in MMN expects top-line results in Q4 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL2khRGv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","BK4585","BK4139","SG9999014039.USD","SG9999014005.SGD","LU2095319765.USD","BK4588","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","DNTH","NDAQ","LU2210150020.SGD","LU2210149790.SGD","LU0314104364.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925504","title":"Dianthus Therapeutics Inc Q1 Income From Operations USD -46.533 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925504","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633925504?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:01","pubTimestamp":1778011261,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXA130C0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633251929","title":"Press Release: Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633251929","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633251929?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:01","pubTimestamp":1778011260,"startTime":"0","endTime":"0","summary":"Early GO decision reached in CAPTIVATE in March 2026 based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A. Claseprubart granted Orphan Drug Designation by FDA for Myasthenia Gravis. Phase 3 registrational trial of claseprubart evaluating 300mg/2mL Q2W and 300mg/2mL Q4W in generalized Myasthenia Gravis  on track to initiate in mid-2026; top-line results anticipated in 2H'28. Phase 2 MoMeNtum trial of claseprubart in Multifocal Motor Neuropathy  ongoing; top-line results on track for Q4'26. Building a rheumatology franchise around DNTH212 with first three priority indications of Sjgren's Disease , Systemic Lupus Erythematosus , and Dermatomyositis . Further strengthened the balance sheet with approximately $719 million in gross proceeds from an underwritten public offering of common stock and pre-funded warrants. Approximately $1.2 billion of cash as of March 31, 2026 provides expected runway into 2030. NEW YORK and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DM","AAN","DNTH","BK4139","BK4007","BK4546","BK4178","BK4539","SLE","BK4077","LENZ","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632477776","title":"Dianthus Therapeutics grants inducement stock options for 135,000 shares at $87.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2632477776","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632477776?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:31","pubTimestamp":1777667471,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics granted equity awards on May 1, 2026 to six newly hired, non-executive employees.Awards consist of non-qualified stock options covering 135,000 shares.Options carry a 10-year term with an exercise price of $87.42 per share.Vesting starts with 25% after one year, then continues in equal monthly installments over 36 months.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL9TMcc3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","DNTH","SG9999014021.USD","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","NDAQ","IE00BGHQF748.EUR","BK4585","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4139","SG9999014005.SGD","LU0314104364.USD","SG9999014013.SGD","BK4588","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632474606","title":"Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632474606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632474606?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:30","pubTimestamp":1777667402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nTUA62KFZL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632648057","title":"Dianthus treatment of myasthenia gravis gets orphan status","url":"https://stock-news.laohu8.com/highlight/detail?id=2632648057","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632648057?lang=en_us&edition=fundamental","pubTime":"2026-05-01 22:58","pubTimestamp":1777647507,"startTime":"0","endTime":"0","summary":"Dianthus (DNTH) Therapeutics was granted FDA orphan designation for claseprubart as a treatment of myasthenia gravis, according to a post to the ag...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-treatment-of-myasthenia-gravis-gets-orphan-status-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-treatment-of-myasthenia-gravis-gets-orphan-status-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","DNTH","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627407430","title":"Dianthus Therapeutics (DNTH) Is Up 10.1% After $719M Raise And Insider Sale Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2627407430","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627407430?lang=en_us&edition=fundamental","pubTime":"2026-04-15 16:08","pubTimestamp":1776240510,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics recently completed an underwritten public offering that raised approximately US$719.00 million in gross proceeds, while its Executive Vice President, CFO & CBO Ryan Savitz exercised options and sold 8,224 shares under a pre-arranged Rule 10b5-1 trading plan.\nInvestor attention has also been drawn to favorable FDA trial updates and encouraging interim data for Dianthus’s lead therapies, which prompted reaffirmed positive analyst coverage despite Savitz now holding no...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dnth/dianthus-therapeutics/news/dianthus-therapeutics-dnth-is-up-101-after-719m-raise-and-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dnth/dianthus-therapeutics/news/dianthus-therapeutics-dnth-is-up-101-after-719m-raise-and-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DNTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626005148","title":"Dianthus CFO Ryan Savitz disposes 8,224 shares for $738,460","url":"https://stock-news.laohu8.com/highlight/detail?id=2626005148","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626005148?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:53","pubTimestamp":1775854393,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics EVP, CFO and CBO Ryan Savitz sold 8,224 shares on April 9.Transaction followed exercise of stock options for 8,224 shares at USD 17.88 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDLc7JkD1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus CFO Ryan Savitz disposes 8,224 shares for $738,460","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626651130","title":"Dianthus Therapeutics announces annual shareholder meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2626651130","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626651130?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:11","pubTimestamp":1775765471,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics scheduled 2026 annual shareholder meeting to be held virtually over Internet May 21, 2026.Ballot includes election of three Class II directors: Sujay Kango, Anne McGeorge, Jonathan Violin.Shareholders to vote on advisory resolution on named executive officer compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDLzQHMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625260919","title":"Dianthus Therapeutics grants 135,000 inducement stock options to eight new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2625260919","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625260919?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:01","pubTimestamp":1775505687,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics issued inducement equity awards on April 1, 2026, covering stock options for 135,000 common shares for eight newly hired non-executive employees.Options carry a 10-year term with an exercise price of $84.56 per share.Vesting starts with 25% on first anniversary of vesting commencement date.Remaining options vest in equal monthly installments over next 36 months.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDL6CcLnP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","IE00BN0W2W23.USD","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","SG9999014013.SGD","IE00B64PRP62.GBP","DNTH","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","BK4588","LU2210149790.SGD","BK4585","NDAQ","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625091616","title":"Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625091616","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625091616?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:01","pubTimestamp":1775505660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nTUA3SQDZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624054404","title":"Dianthus CFO Ryan Savitz disposes of DNTH common shares worth $9.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624054404","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624054404?lang=en_us&edition=fundamental","pubTime":"2026-04-02 05:27","pubTimestamp":1775078858,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics EVP, CFO, CBO Ryan Savitz reported transactions dated March 31, 2026.He sold 114,367 shares in multiple trades at weighted average prices ranging from $78.33 to $85.54.Directly held common shares fell to zero following transactions.Savitz reported continued direct ownership of stock options covering 90,399 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL5cxTCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624440125","title":"Dianthus Therapeutics director Paula Soteropoulos disposes of shares worth $0 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624440125","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624440125?lang=en_us&edition=fundamental","pubTime":"2026-04-02 05:26","pubTimestamp":1775078804,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics director Paula Soteropoulos sold 599 common shares on March 31, 2026 at USD 80.11.Transaction followed exercise of stock options for 599 shares at USD 8.44.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL7Mqd79:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus Therapeutics director Paula Soteropoulos disposes of shares worth $0 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNTH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":122,"code":"91000000","status":"200"}]}}